These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15724942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms that generate and maintain bone cancer pain.
    Mantyh PW, Hunt SP.
    Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone metastases: Part I--Pathophysiology.
    Fisher G, Mayer DK, Struthers C.
    Clin J Oncol Nurs; 1997 Apr; 1(2):29-35. PubMed ID: 9410649
    [Abstract] [Full Text] [Related]

  • 7. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
    Halvorson KG, Sevcik MA, Ghilardi JR, Rosol TJ, Mantyh PW.
    Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
    [Abstract] [Full Text] [Related]

  • 8. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, Ghilardi JR, Rosol TJ, Boustany L, Shelton DL, Mantyh PW.
    Cancer Res; 2005 Oct 15; 65(20):9426-35. PubMed ID: 16230406
    [Abstract] [Full Text] [Related]

  • 9. [Malignant bone pain].
    Thomsen CB, Crawford ME, Sjøgren P.
    Ugeskr Laeger; 1997 Apr 14; 159(16):2364-9. PubMed ID: 9163111
    [Abstract] [Full Text] [Related]

  • 10. Controlling cancer pain with pharmacotherapy.
    Pharo GH, Zhou L.
    J Am Osteopath Assoc; 2007 Dec 14; 107(12 Suppl 7):ES22-32. PubMed ID: 18165374
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms of cancer pain.
    Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP.
    Nat Rev Cancer; 2002 Mar 14; 2(3):201-9. PubMed ID: 11990856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A mechanism-based understanding of bone cancer pain.
    Mantyh PW.
    Novartis Found Symp; 2004 Mar 14; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
    [Abstract] [Full Text] [Related]

  • 14. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
    Pluijm G, Löwik C, Papapoulos S.
    Cancer Treat Rev; 2000 Feb 14; 26(1):11-27. PubMed ID: 10660489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
    Clemons M, Dranitsaris G, Cole D, Gainford MC.
    Oncologist; 2006 Mar 14; 11(3):227-33. PubMed ID: 16549806
    [Abstract] [Full Text] [Related]

  • 17. Clinical features of metastatic bone disease and risk of skeletal morbidity.
    Coleman RE.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708
    [Abstract] [Full Text] [Related]

  • 18. Facilitation and suppression of bone metastasis.
    Mundy GR, Yoneda T.
    Clin Orthop Relat Res; 1995 Mar 15; (312):34-44. PubMed ID: 7634615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.